Windsor Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $3.1M | Sell |
93,316
-450
| -0.5% | -$14.9K | 1.45% | 33 |
|
|
2017
Q1 | $3.01M | Buy |
93,766
+24,350
| +35% | +$781K | 1.38% | 37 |
|
|
2016
Q4 | $2.52M | Sell |
69,416
-42,990
| -38% | -$1.56M | 1.19% | 37 |
|
|
2016
Q3 | $5.17M | Buy |
112,406
+600
| +0.5% | +$27.6K | 2.43% | 17 |
|
|
2016
Q2 | $5.62M | Buy |
111,806
+5,495
| +5% | +$276K | 2.56% | 10 |
|
|
2016
Q1 | $5.69M | Buy |
106,311
+33,916
| +47% | +$1.81M | 2.6% | 10 |
|
|
2015
Q4 | $4.75M | Buy |
72,395
+192
| +0.3% | +$12.6K | 2.31% | 16 |
|
|
2015
Q3 | $4.08M | Sell |
72,203
-35,919
| -33% | -$2.03M | 1.96% | 27 |
|
|
2015
Q2 | $6.39M | Sell |
108,122
-2,488
| -2% | -$147K | 2.75% | 6 |
|
|
2015
Q1 | $6.89M | Buy |
110,610
+2,426
| +2% | +$151K | 3.09% | 3 |
|
|
2014
Q4 | $6.22M | Sell |
108,184
-774
| -0.7% | -$44.5K | 2.96% | 2 |
|
|
2014
Q3 | $5.86M | Sell |
108,958
-744
| -0.7% | -$40K | 2.81% | 3 |
|
|
2014
Q2 | $5.75M | Sell |
109,702
-1,943
| -2% | -$102K | 2.81% | 3 |
|
|
2014
Q1 | $5.9M | Sell |
111,645
-174
| -0.2% | -$9.19K | 2.99% | 2 |
|
|
2013
Q4 | $4.48M | Buy |
111,819
+1,701
| +2% | +$68.2K | 2.48% | 12 |
|
|
2013
Q3 | $4.16M | Buy |
110,118
+3,427
| +3% | +$129K | 2.5% | 9 |
|
|
2013
Q2 | $4.18M | Buy |
+106,691
| New | +$4.18M | 2.65% | 4 |
|